focus -WSS

focus

author：explore 2025-08-12 06:45:21 - browse：2221

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： FDA approves first treatment for ultra

WSS

What the US credit downgrade means for the economy, your finances

Hilary may become 1st tropical storm to make landfall in California in 84 years

Clinical trials must include more disabled people

New safety details link Apellis eye drug to rare cases of blindness

Baltimore teen accused of firing into crowd during block party mass shooting

Micronoma's microbiome cancer diagnostic approach under fire

hotspot

focus

leisure time

Heart attack and stroke risk calculators need revising

What the US credit downgrade means for the economy, your finances

Supreme Court strikes down use of affirmative action

Physician groups backed by private equity giant lobby on mergers

Novavax promises a turnaround & Lilly roils the obesity market

Beware the threat of staffing cuts at the CDC

The cancer drug shortage isn’t new — and neither are the solutions

Vertex non

State Dept. review finds Biden bears some blame for Afghanistan failures

ProMED sees offers of support, but its future remains unclear

focus

Micronoma's microbiome cancer diagnostic approach under fire

Beware the threat of staffing cuts at the CDC

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Trump cancels press conference intended to dispute Georgia election interference charges

What the US credit downgrade means for the economy, your finances

focus

knowledge

leisure time

leisure time